Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3006 |
|
| Actual shortage: | 230 (8%) | |
| Anticipated shortage: | 20 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2747 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-04-30 | 2021-05-17 | 138343 |
| APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-04-09 | 2021-05-17 | 137244 |
| APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2020-07-23 | 2021-05-17 | 120971 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-17 | 122468 |
| APO-ALLOPURINOL | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-17 | 122465 |
| APO-QUINAPRIL/HCTZ | 10MG 12.5MG | TABLET | Resolved | 2021-02-12 | 2021-05-10 | 133994 |
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Resolved | 2021-03-26 | 2021-05-10 | 136403 |
| APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2021-02-19 | 2021-05-10 | 134427 |
| APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2020-10-28 | 2021-05-10 | 127328 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2021-01-29 | 2021-05-03 | 132727 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2021-04-05 | 2021-05-03 | 136814 |
| APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2021-03-19 | 2021-05-03 | 136047 |
| APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2021-04-09 | 2021-05-03 | 137272 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-03-19 | 2021-05-03 | 136030 |
| APO-PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-04-23 | 2021-05-03 | 137965 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2021-04-05 | 2021-05-03 | 136805 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-12-05 | 2021-05-03 | 100281 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2021-04-09 | 2021-05-01 | 137250 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-09 | 2021-05-01 | 137261 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-09 | 2021-05-01 | 137264 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
| APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
| APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
| APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
| APO-OXAZEPAM | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 |